MP police registers FIR against Sresan Pharma, links deaths of children directly to the company

Madhya Pradesh police on Monday registered an FIR on Chennai's Sresan Pharma, alleging that Coldrif syrup manufactured by them was adulterated and was a direct cause for death of 21 children. The proprietor of Sresan Pharma was arrested by MP police on October 9.

Meanwhile, the Enforcement Directorate (ED) launched searches at seven locations in Chennai in connection with the case. The raids are being conducted under the provisions of the Prevention of Money Laundering Act (PMLA) and are linked to Sresan Pharma, the manufacturer of the syrup that is now banned across several states in the country.

Lapses by regulatory authorities

Investigation so far have revealed serious lapses by the Tamil Nadu Food and Drug Administration (TNFDA) in enforcing basic regulatory norms, according to PTI sources at the Central Drugs Standard Control Organisation (CDSCO).


A recent inspection by the CDSCO noted gross non-compliance with Good Manufacturing Practices (GMP) and deplorable working conditions at the facility.

Furthermore, Sresan Pharma failed to register its approved products on the national ‘Sugam’ portal, a mandatory requirement aimed at better monitoring of pharmaceutical manufacturing in India.

The TN government in response suspended two Drug Control Dept officers who were duty bound to do inspections but did not do any inspections in the last two years.

Both the FIRs had scheduled offence and ED registered ECIR.